NEXT Virtual Event for Pharma & Biotech | Register
Pharma & Biotech | NEXT Virtual Conference
With the COVID-19 pandemic, the impact on clinical trials is unmistakable. Join Medidata’s virtual event where we will discuss the challenges COVID-19 is creating for clinical trials, along with practical approaches to ensure the safety of patients, sites, and staff, while keeping clinical trials running.
- Opening remarks
- Risk Assessment, Central Monitoring, and RTSM
- Patient Centricity by Design: The Path to Patient-Centric Solutions
- Enabling Clinical Trials in a Pandemic: Continue Treating Patients and Minimize Risk
Lisa is the Vice President of Product for Risk Based Monitoring capabilities for Medidata Solutions. She has nearly 20 years of pharma, biotech, and medical device industry experience, delivering complex system solutions in support of excellence in clinical trial execution. Lisa has spent time both in consulting and in Information System leadership for Amgen, directing architecture and development of the Clinical Trial Management ecosystem. While at Amgen, Lisa was also allocated to leadership roles within TransCelerate Biopharma, driving industry innovation through delivery of the Shared Investigator Platform and the Investigator Registry.
Bryant has enjoyed nearly 25 years in clinical research domain, mostly comprised of industry leadership in clinical data management and clinical operations. Most notably, he developed and led a global team of clinical data managers in the successful delivery of high quality data in Oncology, Hemophilia and Ophthalmology submissions. Bryant has led workstreams in the identification of innovative and transformative process and tools for future clinical data environments. Immediately prior to joining Medidata, he supported departments in clinical data standards and HEOR research. Bryant is currently the Director, Data Science and Analytics Portfolio where he ensures seamless coordination and oversight between commercialization, marketing, strategy and corporate development operations for Data Science products and solutions.
Alicia Staley is the Sr. Director Patient Engagement for mHealth at Medidata. She has over 20 years of experience in software design and information systems management and works to infuse the patient perspective throughout the product development lifecycle and help engage patients in novel ways.Alicia is also a three-time cancer survivor who has over the past 10 years applied her engineering background to improve the patient experience for those dealing with cancer. As a champion of patient advocacy and engagement, she understands the critical issues facing patients looking to engage in clinical research. With a keen focus on improving access to clinical trials, Alicia is passionate about making a difference for all patients searching for information about clinical trials.
Meena has over 10 years of experience in the Life Sciences industry with focus on project management and delivery of clinical technology solutions. Prior to joining Medidata, Meena worked with PAREXEL International where she was responsible for the development and delivery of IRT/RTSM solutions. Meena has a Master of Science in Management of Projects and Programs from Brandeis University, M.S in Computer Science from SNDT University and a B.S in Physics from University of Mumbai.
T.J. Sharpe is a stage IV melanoma patient sharing his journey through cancer in his Patient #1 Blog. Diagnosed in 2012 with tumors in multiple organs, he has undergone six surgeries and four immunotherapies across two clinical trials. The initial failures, and subsequent response, have been chronicled in his posts. He is a keynote speaker and consultant to the biopharma and clinical research industries, working with major pharmaceutical corporations and as a patient advisor to TransCelerate to bring an educated patient voice as a true stakeholder in challenging healthcare’s status quo. A South Jersey native, T.J. lives in Fort Lauderdale, Florida, with his wife, Jennifer, and two young children, Josie and Tommy, and can be found on Twitter at @TeamTJSharpe.
Liza Bernstein, who is NED (No Evidence of Disease) after three primary cancer diagnoses, is a patient advocate serving a global audience via social media, conference attendance, live-tweeting, speaking and media engagements, and in-person mentoring. She also collaborates, co-designs, and advises across the multi-stakeholder healthcare spectrum to break down silos, foster understanding, promote education and empowerment, and accelerate change. Liza is a Stanford Medicine X founding ePatient scholar, advisor, and former board member, and is Symplur’s Consultant for Insights and Development.
Diagnosed with breast cancer in 2006, AnneMarie embarked on a path of patient advocacy in 2011 when late onset and worsening effects of chemotherapy forced her off her former career path. Her mom, with two separate breast cancer diagnoses at twenty-year intervals, is now living with metastatic disease. AnneMarie sits on a number of scientific advisory boards, serves as a patient advocate on research grant applications and has participated in the peer review process to evaluate applications for funding recommendation and on NCI review panels for cancer center grant renewals. From bench to bedside, she believes the patient voice should be included along the entire continuum of care. AnneMarie has co-authored a number of publications in scientific journals. She has presented posters in both the scientific and advocate sessions at a number of AACR annual meetings and is currently working with research teams and labs at Memorial Sloan Kettering, Lurie Cancer Center, Columbia, USC, and Fred Hutch. With the help of the ACLU, she fought for and obtained her full genetic data set from Myriad labs. She resides in the NYC area and is the author of the blog, Chemobrain: In The Fog, named a top breast cancer blog by Healthline for six consecutive years. Find her on twitter @chemobrainfog.